Blog: Blog2

GPCR News

May 1, 20221 min read

Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer

May 2022 "MONTREAL (CANADA) – May 17, 2022 – Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique...

2 views

0 comments

Mar 1, 20221 min read

March 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial "MONTREAL (CANADA) –...

2 views

0 comments

Jan 1, 20221 min read

January 2022 Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update...

5 views

0 comments